tiprankstipranks
Trending News
More News >
Shield Therapeutics PLC (GB:STX)
LSE:STX
UK Market

Shield Therapeutics (STX) Technical Analysis

Compare
41 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Shield Therapeutics PLC’s (STX) Moving Averages Convergence Divergence (MACD) indicator is 0.23, suggesting Shield Therapeutics PLC is a Buy.
Shield Therapeutics PLC’s (STX) 20-Day exponential moving average is 10.34, while Shield Therapeutics PLC’s (STX) share price is 9.85p, making it a Buy.
Shield Therapeutics PLC’s (STX) 50-Day exponential moving average is 9.50, while Shield Therapeutics PLC’s (STX) share price is 9.85p, making it a Buy.

Shield Therapeutics (STX) Pivot Points

Jan 12, 2026, 02:06 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.83
8.67
9.33
10.17
10.83
11.67
12.33
Fibonacci
8.67
9.24
9.59
10.17
10.74
11.09
11.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Shield Therapeutics (STX) Moving Averages

Jan 12, 2026, 02:06 AM
Period
Simple
Exponential
MA5
10.45Buy
10.37Buy
MA10
10.30Buy
10.41Buy
MA20
10.61Sell
10.34Buy
MA50
9.10Buy
9.50Buy
MA100
8.37Buy
8.27Buy
MA200
5.73Buy
6.25Buy
Shield Therapeutics PLC’s (STX) 10-Day exponential moving average is 10.41, while Shield Therapeutics PLC’s (STX) share price is 9.85p, making it a Buy.
Shield Therapeutics PLC’s (STX) 100-Day exponential moving average is 8.27, while Shield Therapeutics PLC’s (STX) share price is 9.85p, making it a Buy.
Shield Therapeutics PLC’s (STX) stock price is 9.85p and Shield Therapeutics PLC’s (STX) 50-day simple moving average is 9.10, creating a Buy signal.
Shield Therapeutics PLC’s (STX) stock price is 9.85p and Shield Therapeutics PLC’s (STX) 100-day simple moving average is 8.37, creating a Buy signal.
Shield Therapeutics PLC’s (STX) stock price is 9.85p and Shield Therapeutics PLC’s (STX) 200-day simple moving average is 5.73, creating a Buy signal.

Shield Therapeutics (STX) Technical Indicators

Jan 12, 2026, 02:06 AM
Name
Value
Implied Action
RSI (14)
53.90
Neutral
STOCH (9,6)
41.67
Neutral
STOCHRSI (14)
27.78
Neutral
MACD (12,26)
0.23
Buy
ADX (14)
30.44
Neutral
Williams %R
-66.67
Buy
CCI (14)
-42.70
Neutral
ATR (14)
1.02
-
Ultimate Oscillator
47.19
Neutral
ROC
-10.64
Sell
Shield Therapeutics PLC’s (STX) Relative Strength Index (RSI) is 53.90, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Trend Strength Indicator (ADX) is 30.44, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Commodity Channel Index (CCI) is -42.70, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Price Rate of Change (ROC) is -10.64, creating a Sell signal.

FAQ

Is STX a Buy, Hold, or Sell?
Based on STX’s technical indicators, STX is a Buy.
    What is STX’s RSI (14)?
    STX’s RSI (14) is 53.90, which suggests STX is a Neutral.
      What is STX’s MACD?
      STX’s MACD is 0.23, which suggests STX is a Buy.
        What is STX’s 5-day moving average?
        STX’s 5-day moving average is 10.45, which suggests STX is a Buy.
          What is STX’s 20-day moving average?
          STX 20-day moving average is 10.61, which suggests STX is a Sell.
            What is STX’s 50-day moving average?
            STX’s 50-day moving average is 9.10, which suggests STX is a Buy.
              What is STX’s 200-day moving average?
              STX’s 200-day moving average is 5.73, which suggests STX is a Buy.
                What is STX’s Williams % R (14)?
                STX’s Williams % R (14) is -66.67, which suggests STX is a Buy.
                  What is STX’s CCI (14)?
                  STX’s CCI (14) is -42.70, which suggests STX is a Neutral.
                    What is the share price of Shield Therapeutics PLC?